Offline mode

Periostin ELISA

Catalog no.30151132
Regulatory Status
RUO
Kit size
12x8
Method
ELISA
Incubation time
1 x O/N, 1 x 90 min., 1 x 10 min.
Standard range
0 - 2000 ng/mL
Specimen / Volumes
5 µL serum, plasma, cell culture supernatant, nasal lavage fluid, vitreous fluid, tears, BALF
Substrate / isotope
TMB 450nm
instructions for useMSDS

Introduction

Periostin, also known as Osteoblast-specific factor 2 (OSF-2), is an extracellular matrix protein of approximately 90 kDa belonging to the fasciclin family¹. Periostin protein is composed of a cystein-rich region (EM!) and a four-coiled fasciclin-like repeats region (FASO). Type I collagen and fibronectin have been found to bind to the EMJ domain, Tenascin-C to the FAS1 domain². Periostin is upregulated by stimulation with Th2 cytokines (IL-4. IL-13)³. The periostin level correlates with both Th2-inflammation and fibrosis⁴.

The concentration of periostin in biological samples is increased in many diseases including atopic dermatitis, asthma, scleroderma, cholangiocellular carcinoma and diabetic retinopathy⁵-⁹. It has also been suggested that periostin may serve as a companion diagnostic marker for asthma therapeutics¹⁰.

It was originally identified in cells from the mesenchymal lineage, inducing a vicious cycle in the IL-4/Il-13 pathway. Fig. 1 Periostin as an inducer of a vicious cycle in the IL-4/Il-13 release

This ELISA kit specifically measures natural and recombinant human periostin. It does not react with either β ig-h3 or mouse periostin.

distributed by TECAN-IBL International

For concrete data please consult the Instruction for Use in the download box on the top right side.

  1. Takeshita S et al. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I . Biochem J 1993; 284; 271-278.
  2. Kii I et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 2010: 285: 2028-2039.
  3. Takayama G et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL -4 and ll -13 signals. J Allergy Clin lmmunol 2006; 118: 98-104.
  4. Okamoto M et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011; 37: 111 9-11 27.
  5. Masuoka M et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J C!in Invest 2012; 122: 2590-2600.
  6. Kanemitsu Y et al.Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin lmmunol 2013; 132: 305-312.
  7. Yamaguchi Y et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol 2013; 188: 717-725.
  8. Fujimoto K et al. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep 2011; 25: 1211-1216.
  9. Yoshida S et al. Increased expresston of periostin in vitreous and fibrovascular membranes obtained from patients with prolrferative diabetic retinopathy. Invest Ophthalmol Vis Sci2011: 52: 5670-5678.
  10. Corren Jet al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011: 385: 1088-1098.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.